Austar Lifesciences Limited, an investment holding company, provides integrated engineering solutions to pharmaceutical manufacturers and research institutes in Mainland China and internationally. It operates through six segments: Liquid and Bioprocess System; Clean Room and Automation Control and Monitoring System; Powder and Solid System; GMP Compliance Service; Life Science Consumables; and Distribution and Agency of Pharmaceutical Equipment. The company offers liquid and bioprocess systems, including pharmaceutical water, and liquid preparation and bioprocess systems; powder and solid systems; clean utility equipment and systems; clean room, automation control, and monitor systems; and freeze-dryer, sterile filling, and visual inspection equipment. It also provides pharmaceutical process contamination control products; packaging and aseptic containment products; biosafety and lab animal equipment and consumables; laboratory one-stop solutions; and single-use bioprocess equipment and consumables. In addition, the company offers design, quality risk control, consulting, research and development support, process engineering, digitalization construction, after-sale, on-site, upgrading, relocation, and asset management services. Further, it is involved in the agency and distribution of pharmaceutical equipment, as well as provides assembly and pre-assembly services. The company was founded in 1991 and is headquartered in Shanghai, China.
Last 10 Buy Signals
Date |
Signal |
@ |
ZI | May 3 - 10:20 | $16.48 |
RYAAY | May 3 - 10:20 | $138.96 |
RSS3USD | May 3 - 10:19 | 0.355 |
MKRUSD | May 3 - 10:20 | $2 760.32 |
MAR | May 3 - 10:20 | $235.87 |
FROG | May 3 - 10:20 | $39.95 |
IMXUSD | May 3 - 10:20 | $2.23 |
GFS | May 3 - 10:20 | $49.06 |
CG | May 3 - 10:19 | $40.91 |
^IBEX | May 3 - 10:04 | PTS10 851 |